Transfer from: ammonia-based observation For Biotech, the key to influence its expectations is undoubtedly “clinical data”. In the United States equity market, the publication of clinical data on the key casing lines of Biotech is just “casino”: either birth or death. Of course, there are numerous links in the pharmaceutical industry, and it is not limited to clinical data that determine biotechnological deaths. After clinical success, industrialization and commercialization remain relevant t...